USPTO serial 98414678
POLARIZED
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with POLARIZED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Woodland Hills, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen White Zelano and Branigan PC2200 Clarendon Blvd Suite 1400Arlington, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Alcohol for pharmaceutical purposes; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Balms for pharmaceutical purposes; Bromine for pharmaceutical purposes; Capsules sold empty for pharmaceuticals; Cardiovascular pharmaceuticals; Charcoal for pharmaceutical purposes; Creosote for pharmaceutical purposes; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Ethers for pharmaceutical purposes; Gelatin capsules sold empty for pharmaceuticals; Gelatin capsules, empty, for pharmaceuticals; Guaiacol for pharmaceutical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Malt for pharmaceutical purposes; Mint for pharmaceutical purposes; Ocular pharmaceuticals; Pepsins for pharmaceutical purposes; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2025 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Nov 13, 2025 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Nov 12, 2025 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Nov 7, 2025 | KSNS | NOTICE OF SUSPENSION EMAILED - ADMIN REVIEW | — |
| Nov 7, 2025 | KSAD | SUSPENDED PENDING ADMINISTRATIVE REVIEW | — |
| Feb 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 27, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2024 | NWAP | NEW APPLICATION ENTERED | — |